Zepp Health (ZEPP) Competitors $2.76 -0.06 (-2.13%) Closing price 07/2/2025 03:59 PM EasternExtended Trading$2.75 -0.01 (-0.36%) As of 07/2/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ZEPP vs. LTRX, MKFG, SILC, OSS, INVE, ALOT, QMCO, LINK, INTZ, and FOXXShould you be buying Zepp Health stock or one of its competitors? The main competitors of Zepp Health include Lantronix (LTRX), Markforged (MKFG), Silicom (SILC), One Stop Systems (OSS), Identiv (INVE), AstroNova (ALOT), Quantum (QMCO), Interlink Electronics (LINK), Intrusion (INTZ), and Foxx Development (FOXX). These companies are all part of the "computer hardware" industry. Zepp Health vs. Its Competitors Lantronix Markforged Silicom One Stop Systems Identiv AstroNova Quantum Interlink Electronics Intrusion Foxx Development Lantronix (NASDAQ:LTRX) and Zepp Health (NYSE:ZEPP) are both small-cap computer hardware companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, risk, media sentiment, valuation, dividends and profitability. Do insiders & institutionals believe in LTRX or ZEPP? 39.4% of Lantronix shares are held by institutional investors. Comparatively, 52.6% of Zepp Health shares are held by institutional investors. 1.6% of Lantronix shares are held by company insiders. Comparatively, 36.0% of Zepp Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has stronger earnings and valuation, LTRX or ZEPP? Lantronix has higher earnings, but lower revenue than Zepp Health. Lantronix is trading at a lower price-to-earnings ratio than Zepp Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLantronix$160.33M0.70-$4.52M-$0.22-13.09Zepp Health$182.60M0.22-$75.73M-$5.02-0.55 Which has more volatility and risk, LTRX or ZEPP? Lantronix has a beta of 1.51, suggesting that its stock price is 51% more volatile than the S&P 500. Comparatively, Zepp Health has a beta of 0.85, suggesting that its stock price is 15% less volatile than the S&P 500. Is LTRX or ZEPP more profitable? Lantronix has a net margin of -5.84% compared to Zepp Health's net margin of -44.54%. Lantronix's return on equity of -7.03% beat Zepp Health's return on equity.Company Net Margins Return on Equity Return on Assets Lantronix-5.84% -7.03% -4.14% Zepp Health -44.54%-23.60%-11.98% Do analysts rate LTRX or ZEPP? Lantronix currently has a consensus price target of $3.83, suggesting a potential upside of 33.10%. Zepp Health has a consensus price target of $13.87, suggesting a potential upside of 402.54%. Given Zepp Health's higher probable upside, analysts clearly believe Zepp Health is more favorable than Lantronix.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lantronix 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Zepp Health 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media refer more to LTRX or ZEPP? In the previous week, Lantronix had 6 more articles in the media than Zepp Health. MarketBeat recorded 9 mentions for Lantronix and 3 mentions for Zepp Health. Lantronix's average media sentiment score of 0.70 beat Zepp Health's score of 0.14 indicating that Lantronix is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Lantronix 1 Very Positive mention(s) 4 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Zepp Health 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryLantronix beats Zepp Health on 10 of the 15 factors compared between the two stocks. Get Zepp Health News Delivered to You Automatically Sign up to receive the latest news and ratings for ZEPP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ZEPP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZEPP vs. The Competition Export to ExcelMetricZepp HealthMEDICAL INFO SYS IndustryMedical SectorNYSE ExchangeMarket Cap$40.89M$1.99B$5.54B$20.53BDividend YieldN/AN/A5.39%3.77%P/E Ratio-0.5533.4026.1727.85Price / Sales0.2215.92413.5537.49Price / CashN/A55.6636.1321.91Price / Book0.168.588.024.55Net Income-$75.73M-$62.39M$3.15B$984.95M7 Day Performance0.73%0.44%1.48%2.31%1 Month Performance14.57%2.49%3.66%4.85%1 Year Performance7.81%3.30%34.68%13.81% Zepp Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZEPPZepp Health2.8112 of 5 stars$2.76-2.1%$13.87+402.5%+11.3%$40.89M$182.60M-0.551,230LTRXLantronix3.5344 of 5 stars$2.87-4.7%$3.83+33.6%-20.0%$117.06M$160.33M-13.05350MKFGMarkforged0.969 of 5 stars$4.60-3.0%$5.00+8.7%+12.2%$95.44M$85.09M-1.06370News CoverageGap DownSILCSilicom2.2923 of 5 stars$15.47-1.3%N/A+1.4%$88.94M$58.11M-7.97320Positive NewsOSSOne Stop Systems2.0986 of 5 stars$3.55-4.6%$4.50+26.8%+75.0%$80.31M$54.69M-5.30110Positive NewsHigh Trading VolumeINVEIdentiv4.0876 of 5 stars$3.26+3.5%$6.50+99.4%-24.1%$74.39M$26.63M1.08330News CoverageHigh Trading VolumeALOTAstroNova0.886 of 5 stars$11.59+24.6%N/A-15.7%$70.64M$151.28M-5.44340High Trading VolumeQMCOQuantum2.5574 of 5 stars$9.97+10.3%$19.00+90.6%+17.7%$62.83M$311.60M0.00900Trending NewsGap DownLINKInterlink Electronics0.8065 of 5 stars$7.55+6.6%N/A+102.7%$48.94M$11.22M83.8990Positive NewsGap DownHigh Trading VolumeINTZIntrusion2.2334 of 5 stars$2.29+2.7%$6.25+172.9%+118.5%$44.37M$5.77M-1.7060FOXXFoxx DevelopmentN/A$5.49-2.7%N/AN/A$38.24MN/A-4.69N/AGap Up Related Companies and Tools Related Companies Lantronix Alternatives Markforged Alternatives Silicom Alternatives One Stop Systems Alternatives Identiv Alternatives AstroNova Alternatives Quantum Alternatives Interlink Electronics Alternatives Intrusion Alternatives Foxx Development Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ZEPP) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zepp Health Corporation Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Zepp Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.